Principal Investigator
David Kerman
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20250165
Clinical Trial Summary
Sanofi-Aventis-DRI18450-A Phase 2, multicenter, randomized, double-blind, placebo controlled, dose-ranging study to evaluate the efficacy and safety of SAR442970 in adults with moderate to severe
Crohn’s disease
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Niurka Colina
Phone Number
+1 (305) 2436405
Email
nxc610@miami.edu